These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Early findings after integration of donor-derived cell-free DNA into clinical care following pediatric heart transplantation. Feingold B; Rose-Felker K; West SC; Zinn MD; Berman P; Moninger A; Huston A; Stinner B; Xu Q; Zeevi A; Miller SA Pediatr Transplant; 2022 Feb; 26(1):e14124. PubMed ID: 34420244 [TBL] [Abstract][Full Text] [Related]
7. Short-term clinical outcomes and predicted cost savings of dd-cfDNA-led surveillance after pediatric heart transplantation. Feingold B; Rose-Felker K; West SC; Miller SA; Zinn MD Clin Transplant; 2023 May; 37(5):e14933. PubMed ID: 36779524 [TBL] [Abstract][Full Text] [Related]
8. Relationship between donor-derived cell-free DNA and tissue-based rejection-related transcripts in heart transplantation. Lee DH; Usmani A; Wu R; Wicks T; Noh CY; Burke R; Ravichandran V; Wolf-Doty T; Dumitru I; Oliveira GH; Berman P; Mackie B J Heart Lung Transplant; 2024 Jul; 43(7):1118-1125. PubMed ID: 38373559 [TBL] [Abstract][Full Text] [Related]
9. Single-center utilization of donor-derived cell-free DNA testing in the management of heart transplant patients. Gondi KT; Kao A; Linard J; Austin BA; Everley MP; Fendler TJ; Khumri T; Lawhorn SL; Magalski A; Nassif ME; Sperry BW; Vodnala D; Borkon AM Clin Transplant; 2021 May; 35(5):e14258. PubMed ID: 33606316 [TBL] [Abstract][Full Text] [Related]
10. Comparing Plasma Donor-derived Cell-free DNA to Gene Expression in Endomyocardial Biopsies in the Trifecta-Heart Study. Halloran PF; Reeve J; Mackova M; Madill-Thomsen KS; Demko Z; Olymbios M; Campbell P; Melenovsky V; Gong T; Hall S; Stehlik J Transplantation; 2024 Sep; 108(9):1931-1942. PubMed ID: 38538559 [TBL] [Abstract][Full Text] [Related]
11. Initiation of noninvasive surveillance for allograft rejection in heart transplant patients > 1 year after transplant. Kewcharoen J; Kim J; Cummings MB; Leitner KB; Suzuki EMB; Banerjee D; Lum CJ Clin Transplant; 2022 Mar; 36(3):e14548. PubMed ID: 34843112 [TBL] [Abstract][Full Text] [Related]
12. Sex-specific patterns of donor-derived cell-free DNA in heart transplant rejection: An analysis from the Genomic Research Alliance for Transplantation (GRAfT). DeFilippis EM; Sweigart B; Khush KK; Shah P; Agbor-Enoh S; Valantine HA; Vest AR J Heart Lung Transplant; 2024 Jul; 43(7):1135-1141. PubMed ID: 38460620 [TBL] [Abstract][Full Text] [Related]
13. Comparison of two donor-derived cell-free DNA tests and a blood gene-expression profile test in heart transplantation. Rodgers N; Gerding B; Cusi V; Vaida F; Tada Y; Morris GP; Adler ED; Stehlik J; Kim PJ Clin Transplant; 2023 Jun; 37(6):e14984. PubMed ID: 37036133 [TBL] [Abstract][Full Text] [Related]
14. HLA-DRB1 mismatch-based identification of donor-derived cell free DNA (dd-cfDNA) as a marker of rejection in heart transplant recipients: A single-institution pilot study. Sorbini M; Togliatto GM; Simonato E; Boffini M; Cappuccio M; Gambella A; Arruga F; Mora N; Marro M; Caorsi C; Mansouri M; Magistroni P; Delsedime L; Papotti MG; Amoroso A; Rinaldi M; Vaisitti T; Deaglio S J Heart Lung Transplant; 2021 Aug; 40(8):794-804. PubMed ID: 34134912 [TBL] [Abstract][Full Text] [Related]
15. Donor-derived cell-free DNA (dd-cfDNA) for detection of allograft rejection in pediatric kidney transplants. Puliyanda DP; Swinford R; Pizzo H; Garrison J; De Golovine AM; Jordan SC Pediatr Transplant; 2021 Mar; 25(2):e13850. PubMed ID: 33217125 [TBL] [Abstract][Full Text] [Related]
16. Multi-centre analytical performance verification of an IVD assay to quantify donor-derived cell-free DNA in solid organ transplant recipients. Casas S; Tangprasertchai NS; Oikonomaki K; Mathers S; Sollet ZC; Samara S; Liu J; Burlinson ND; Constantoulakis P; Villard J; Viard T HLA; 2024 May; 103(5):e15518. PubMed ID: 38733247 [TBL] [Abstract][Full Text] [Related]
17. Validation of a Clinical-Grade Assay to Measure Donor-Derived Cell-Free DNA in Solid Organ Transplant Recipients. Grskovic M; Hiller DJ; Eubank LA; Sninsky JJ; Christopherson C; Collins JP; Thompson K; Song M; Wang YS; Ross D; Nelles MJ; Yee JP; Wilber JC; Crespo-Leiro MG; Scott SL; Woodward RN J Mol Diagn; 2016 Nov; 18(6):890-902. PubMed ID: 27727019 [TBL] [Abstract][Full Text] [Related]
18. Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: Results from a prospective observational study. Oellerich M; Shipkova M; Asendorf T; Walson PD; Schauerte V; Mettenmeyer N; Kabakchiev M; Hasche G; Gröne HJ; Friede T; Wieland E; Schwenger V; Schütz E; Beck J Am J Transplant; 2019 Nov; 19(11):3087-3099. PubMed ID: 31062511 [TBL] [Abstract][Full Text] [Related]
19. Observed elevated donor-derived cell free DNA in orthotopic heart transplant recipients without clinical evidence of rejection. Afzal A; Alam A; van Zyl JS; Zafar H; Felius J; Hall SA; Carey SA Clin Transplant; 2022 Mar; 36(3):e14549. PubMed ID: 34863042 [TBL] [Abstract][Full Text] [Related]
20. Incorporation of Donor-derived Cell-free DNA Into Clinical Practice for Renal Allograft Management. Qazi Y; Patel A; Fajardo M; McCormick S; Fehringer G; Ahmed E; Malhotra M; Demko ZP; Billings PR; Tabriziani H; Gauthier P Transplant Proc; 2021 Dec; 53(10):2866-2872. PubMed ID: 34774309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]